Sanctuary Advisors LLC Takes Position in Humana Inc. $HUM

Sanctuary Advisors LLC purchased a new position in Humana Inc. (NYSE:HUMFree Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,439 shares of the insurance provider’s stock, valued at approximately $1,763,000.

Other institutional investors have also made changes to their positions in the company. Johnson Financial Group Inc. acquired a new stake in shares of Humana during the 2nd quarter valued at $26,000. Trust Co. of Vermont purchased a new position in shares of Humana during the 2nd quarter valued at $28,000. Bogart Wealth LLC increased its stake in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. MidFirst Bank acquired a new position in shares of Humana in the second quarter worth $35,000. Finally, Montag A & Associates Inc. raised its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Up 0.1%

Humana stock opened at $390.06 on Thursday. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company’s fifty day moving average price is $384.44 and its two-hundred day moving average price is $286.38. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $46.84 billion, a price-to-earnings ratio of 36.90, a PEG ratio of 2.22 and a beta of 0.72.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.27 earnings per share. On average, analysts forecast that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HUM. Raymond James Financial cut Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target for the company in a report on Wednesday, July 29th. Lake Street Capital assumed coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 14th. Finally, Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective on the stock in a research report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $403.91.

Check Out Our Latest Stock Analysis on Humana

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Further Reading

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.